· Virtual Science AI has introduced an intelligent Q&A strategic search function that provides instant, customised insights about disease areas and treatments.
· The new enhancement transforms medical data analysis by delivering answers to complex strategic questions in seconds, accelerating life science decision-making and therapy development.
· Virtual Science AI's pharma-compliant platform seamlessly integrates with existing pharmaceutical processes and systems.
· By combining advanced AI technology with Human-in-the-Loop (HITL) validation, the platform achieves exceptional accuracy and speed, setting new standards for healthcare insights without compromising quality.
LONDON, 29 January 2025 (GLOBE
NEWSWIRE): Virtual Science AI has established itself as a trusted
partner for life science teams. Using its proprietary insight management and advisory
panel solutions, it transforms complex scientific data analysis into clear strategic
insights.
Through continuous
R&D investment, the company has developed sophisticated SOC2 Type 2
Certified AI systems that continuously evolve through machine learning,
incorporating new data and feedback to enhance their analytical capabilities.
This unique methodology, which also incorporates expert human validation
(Human-in-the-Loop), allows Virtual Science AI to deliver unparalleled accuracy
while maintaining the agility needed in today's fast-paced healthcare
environment.
Building on this robust foundation, today we unveil a
new real-time, intelligent Q&A strategic search feature.
This new advanced Q&A
search feature provides real-time summaries for data queries in seconds,
helping life science teams make faster, better-informed decisions. As the
platform serves users worldwide, the system offers country-specific insights
for complex strategic queries.
Virtual Science AI Q&A
feature is a game-changer for life science companies that value agility and
need real-time actionable insights to drive change quickly, effectively, and at
scale.
Tom Hughes, CEO, Virtual Science AI, explains
the impact of the new platform functionality: "With the enhancement to
Virtual Science AI's medical intelligence platform, the new Q&A search feature
enables life science teams to get strategic answers to questions in seconds vs
traditional methods of analyzing complex scientific data that could take
months” Dr. Marco
Avila, Chief Medical Officer, Virtual Science AI, stated: "This advanced AI search feature
is one our customers have requested and is designed to enhance strategic
agility and improve overall population health." For further information about Virtual Science AI’s insight
solutions, visit: www.virtualscienceai.com.
About Virtual Science AI
Virtual Science AI is a global provider of AI-driven
insight management and advisory panel solutions for R&D, Medical Affairs,
Public Affairs, Pricing & Access, and Commercial functions in life science
and healthcare companies. Their proprietary medical intelligence platform
transforms complex scientific data into actionable insights, empowering life
science teams to drive rapid, effective change at scale.
Headquartered in London and with operations across
Europe, North America, Asia Pacific, and Latin America, Virtual Science AI
delivers cutting-edge software as a service (SaaS) solutions for the life-science
and healthcare sectors. The company partners with over 20 leading
pharmaceutical companies and numerous biotechnology firms.
END Media Contact Contact: Alison Doughty Phone: +44 (0)7703 611 620 Email: alison.doughty@virtualscienceai.com
